A citation-based method for searching scientific literature

Daphne Esquivel-Sada, Emmanuelle Lévesque, Julie Hagan, Bartha Maria Knoppers, Jacques Simard. Healthc Policy 2019
Times Cited: 8







List of co-cited articles
40 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
48
62

Personalized breast cancer screening strategies: A systematic review and quality assessment.
Marta Román, Maria Sala, Laia Domingo, Margarita Posso, Javier Louro, Xavier Castells. PLoS One 2019
15
50

Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
18
50

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
66
50

Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Yvonne Wengström, D Gareth Evans, Louise S Donnelly, Mireille J M Broeders. Breast 2018
18
50

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
494
50

Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
Linda Rainey, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders, Daniëlle van der Waal. Psychooncology 2019
18
37

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
17
37

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
90
37

Health professionals' perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease.
Svetlana Puzhko, Justin Gagnon, Jacques Simard, Bartha Maria Knoppers, Sophia Siedlikowski, Gillian Bartlett. Public Health Rev 2019
13
37

Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Heidi D Nelson, Rochelle Fu, Amy Cantor, Miranda Pappas, Monica Daeges, Linda Humphrey. Ann Intern Med 2016
250
37


Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
125
37

Stratified cancer screening: the practicalities of implementation.
T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles,[...]. Public Health Genomics 2013
38
37

European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders. BMC Cancer 2020
9
37

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
30
25

A qualitative study on a decision aid for breast cancer screening: Views from women and health professionals.
A Toledo-Chávarri, M Rué, N Codern-Bové, M Carles-Lavila, L Perestelo-Pérez, M J Pérez-Lacasta, M Feijoo-Cid. Eur J Cancer Care (Engl) 2017
18
25

Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
583
25

Incorporating genomics into breast and prostate cancer screening: assessing the implications.
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
62
25

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
Celine M Vachon, Christopher G Scott, Rulla M Tamimi, Deborah J Thompson, Peter A Fasching, Jennifer Stone, Melissa C Southey, Stacey Winham, Sara Lindström, Jenna Lilyquist,[...]. Breast Cancer Res 2019
16
25

Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C Gard, Jessica W T Leung, Jeffrey A Tice, Celine M Vachon, Steven R Cummings, Karla Kerlikowske,[...]. Breast Cancer Res Treat 2016
76
25

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
696
25

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
50
25

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
25

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
101
25


Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Evan R Myers, Patricia Moorman, Jennifer M Gierisch, Laura J Havrilesky, Lars J Grimm, Sujata Ghate, Brittany Davidson, Ranee Chatterjee Mongtomery, Matthew J Crowley, Douglas C McCrory,[...]. JAMA 2015
289
25

Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study.
Stephanie Archer, Chantal Babb de Villiers, Fiona Scheibl, Tim Carver, Simon Hartley, Andrew Lee, Alex P Cunningham, Douglas F Easton, Jennifer G McIntosh, Jon Emery,[...]. PLoS One 2020
19
25

Screening for breast cancer with mammography.
Peter C Gøtzsche, Karsten Juhl Jørgensen. Cochrane Database Syst Rev 2013
449
25

Breast-cancer screening--viewpoint of the IARC Working Group.
Béatrice Lauby-Secretan, Chiara Scoccianti, Dana Loomis, Lamia Benbrahim-Tallaa, Véronique Bouvard, Franca Bianchini, Kurt Straif. N Engl J Med 2015
385
25

Assessing and managing breast cancer risk: clinicians' current practice and future needs.
Ian M Collins, Emma Steel, G Bruce Mann, Jon D Emery, Adrian Bickerstaffe, Alison Trainer, Phyllis Butow, Marie Pirotta, Antonis C Antoniou, Jack Cuzick,[...]. Breast 2014
32
25

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.
Lorna McWilliams, Victoria G Woof, Louise S Donnelly, Anthony Howell, D Gareth Evans, David P French. BMC Cancer 2020
11
25

Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial.
Anna Pons-Rodriguez, Carles Forné Izquierdo, Jordi Vilaplana-Mayoral, Inés Cruz-Esteve, Isabel Sánchez-López, Mercè Reñé-Reñé, Cristina Cazorla, Marta Hernández-Andreu, Gisela Galindo-Ortego, Montserrat Llorens Gabandé,[...]. BMJ Open 2020
5
40

Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider.
Emmanuelle Lévesque, Emily Kirby, Ineke Bolt, Bartha Maria Knoppers, Inez de Beaufort, Nora Pashayan, Martin Widschwendter. Public Health Genomics 2018
10
25

Barriers and Facilitators to Patient-Provider Communication When Discussing Breast Cancer Risk to Aid in the Development of Decision Support Tools.
Haeseung Yi, Tong Xiao, Parijatham S Thomas, Alejandra N Aguirre, Cindy Smalletz, Jill Dimond, Joseph Finkelstein, Katherine Infante, Meghna Trivedi, Raven David,[...]. AMIA Annu Symp Proc 2015
16
25

Cancer screening risk literacy of physicians in training: An experimental study.
Dafina Petrova, Guiliana Mas, Gorka Navarrete, Tania Tello Rodriguez, Pedro J Ortiz, Rocio Garcia-Retamero. PLoS One 2019
8
25

Implementing a Population-Based Breast Cancer Risk Assessment Program.
Erica Silver, Neil Wenger, Zhuoer Xie, David Elashoff, Kristina Lee, Lisa Madlensky, Jacqueline Trent, Antonia Petruse, Liliana Johansen, Arash Naeim. Clin Breast Cancer 2019
6
33

Healthcare professionals' behaviour regarding the implementation of shared decision-making in screening programmes: A systematic review.
María José Hernández-Leal, María José Pérez-Lacasta, María Feijoo-Cid, Vanesa Ramos-García, Misericòrdia Carles-Lavila. Patient Educ Couns 2021
4
50

Cost-effectiveness of risk-based breast cancer screening: A systematic review.
Shah Alam Khan, Karla Vanessa Hernandez-Villafuerte, Muchandifunga Trust Muchadeyi, Michael Schlander. Int J Cancer 2021
5
40

Psychological impact of providing women with personalised 10-year breast cancer risk estimates.
David P French, Jake Southworth, Anthony Howell, Michelle Harvie, Paula Stavrinos, Donna Watterson, Sarah Sampson, D Gareth Evans, Louise S Donnelly. Br J Cancer 2018
27
25

The contributions of breast density and common genetic variation to breast cancer risk.
Celine M Vachon, V Shane Pankratz, Christopher G Scott, Lothar Haeberle, Elad Ziv, Matthew R Jensen, Kathleen R Brandt, Dana H Whaley, Janet E Olson, Katharina Heusinger,[...]. J Natl Cancer Inst 2015
120
12

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
352
12

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
Jolyn Hersch, Alexandra Barratt, Jesse Jansen, Les Irwig, Kevin McGeechan, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Nehmat Houssami, Kirsten McCaffery. Lancet 2015
179
12

Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.
María José Pérez-Lacasta, Montserrat Martínez-Alonso, Montse Garcia, Maria Sala, Lilisbeth Perestelo-Pérez, Carmen Vidal, Núria Codern-Bové, Maria Feijoo-Cid, Ana Toledo-Chávarri, Àngels Cardona,[...]. PLoS One 2019
18
12



Breast cancer incidence and overdiagnosis in Catalonia (Spain).
Montserrat Martinez-Alonso, Ester Vilaprinyo, Rafael Marcos-Gragera, Montserrat Rue. Breast Cancer Res 2010
33
12

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
322
12

Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
Anup Tank, Hannah M Peterson, Vivian Pera, Syeda Tabassum, Anais Leproux, Thomas O'Sullivan, Eric Jones, Howard Cabral, Naomi Ko, Rita S Mehta,[...]. Breast Cancer Res 2020
8
12

Mapping infectious disease hospital surge threats to lessons learnt in Singapore: a systems analysis and development of a framework to inform how to DECIDE on planning and response strategies.
Shweta R Singh, Richard Coker, Hubertus J-M Vrijhoef, Yee Sin Leo, Angela Chow, Poh Lian Lim, Qinghui Tan, Mark I-Cheng Chen, Zoe Jane-Lara Hildon. BMC Health Serv Res 2017
42
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.